• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Revision of diagnostic guidelines for Kawasaki disease (6th revised edition).

作者信息

Kobayashi Tohru, Ayusawa Mamoru, Suzuki Hiroyuki, Abe Jun, Ito Shuichi, Kato Taichi, Kamada Masahiro, Shiono Junko, Suda Kenji, Tsuchiya Keiji, Nakamura Tsuneyuki, Nakamura Yoshikazu, Nomura Yuichi, Hamada Hiromichi, Fukazawa Ryuji, Furuno Kenji, Matsuura Hiroyuki, Matsubara Tomoyo, Miura Masaru, Takahashi Kei

机构信息

Department of Management and Strategy, National Center for Child Health and Development, Setagaya-ku, Japan.

Department of Pediatrics and Child Health, Nihon University, Itabashi-ku, Japan.

出版信息

Pediatr Int. 2020 Oct;62(10):1135-1138. doi: 10.1111/ped.14326. Epub 2020 Oct 1.

DOI:10.1111/ped.14326
PMID:33001522
Abstract
摘要

相似文献

1
Revision of diagnostic guidelines for Kawasaki disease (6th revised edition).川崎病诊断指南（第6版修订版）修订内容
Pediatr Int. 2020 Oct;62(10):1135-1138. doi: 10.1111/ped.14326. Epub 2020 Oct 1.
2
Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition).川崎病诊断指南（第5修订版）修订版
Pediatr Int. 2005 Apr;47(2):232-4. doi: 10.1111/j.1442-200x.2005.02033.x.
3
What are the main revised points in the 6th diagnostic guidelines for Kawasaki disease?川崎病第6版诊断指南的主要修订要点有哪些？
Pediatr Int. 2020 Oct;62(10):1133-1134. doi: 10.1111/ped.14423.
4
[The mucocutaneous lymph node syndrome or Kawasaki disease].[黏膜皮肤淋巴结综合征或川崎病]
Helv Paediatr Acta. 1979 May;34(2):161-6.
5
Diagnostic guidelines for Kawasaki disease.川崎病诊断指南。
Circulation. 2001 Jan 16;103(2):335-6. doi: 10.1161/01.cir.103.2.335.
6
Calculated decisions: Kawasaki disease diagnostic criteria.经过计算得出的决策：川崎病诊断标准。
Pediatr Emerg Med Pract. 2020 Feb 2;17(1):CD1-CD2.
7
Diagnostic guidelines for Kawasaki disease. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease.川崎病诊断指南。美国心脏协会风湿热、心内膜炎及川崎病委员会
Am J Dis Child. 1990 Nov;144(11):1218-9.
8
Mucocutaneous lymph node syndrome in adults. Differentiation from toxic shock syndrome.成人黏膜皮肤淋巴结综合征。与中毒性休克综合征的鉴别。
Am J Med. 1986 Apr;80(4):724-8. doi: 10.1016/0002-9343(86)90833-8.
9
Acute febrile mucocutaneous lymph node syndrome (Kawasaki disease).急性发热性皮肤黏膜淋巴结综合征（川崎病）。
J R Coll Gen Pract. 1986 Sep;36(290):430.
10
Mucocutaneous lymph node syndrome (Kawasaki syndrome): a case report.黏膜皮肤淋巴结综合征（川崎综合征）：一例报告。
Turk J Pediatr. 1988 Jan-Mar;30(1):51-4.

引用本文的文献

1
Incomplete Kawasaki disease presenting primarily with cough: a case report and brief literature review.主要以咳嗽为表现的不完全川崎病：一例报告及文献简要综述
BMC Pediatr. 2025 Aug 20;25(1):632. doi: 10.1186/s12887-025-05957-2.
2
Prognostic nutritional index as a biomarker for identifying coronary artery lesions in Kawasaki disease.预后营养指数作为川崎病冠状动脉病变识别的生物标志物。
J Pediatr (Rio J). 2025 Aug 18;101(5):101436. doi: 10.1016/j.jped.2025.101436.
3
Atypical Presentation of Kawasaki Disease With Coronary Artery Aneurysms in a 2.5-Month-Old Infant: A Case Report From Syria.
一名2.5个月大婴儿患川崎病伴冠状动脉瘤的非典型表现：来自叙利亚的病例报告
Clin Med Insights Case Rep. 2025 Aug 5;18:11795476251359774. doi: 10.1177/11795476251359774. eCollection 2025.
4
The future of Kawasaki disease management: data-driven innovations from bedside to bench and back again.川崎病管理的未来：从床边到实验室再回归床边的数据驱动创新。
Pediatr Res. 2025 Jul 30. doi: 10.1038/s41390-025-04302-8.
5
The Significance of Elevated sST2 in Children with Kawasaki Disease.可溶性ST2升高在川崎病患儿中的意义
Children (Basel). 2025 Jun 30;12(7):868. doi: 10.3390/children12070868.
6
[Role and mechanism of copper overload-mediated endoplasmic reticulum stress in vascular endothelial injury in Kawasaki disease].[铜过载介导的内质网应激在川崎病血管内皮损伤中的作用及机制]
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jul 15;27(7):842-849. doi: 10.7499/j.issn.1008-8830.2412085.
7
Overcoming the Challenges of Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Case Report.克服川崎病中静脉注射免疫球蛋白抵抗的挑战：一例报告
JNMA J Nepal Med Assoc. 2024 Dec;62(280):844-846. doi: 10.31729/jnma.8837. Epub 2024 Dec 31.
8
The predictive value of urinary albumin-to-creatinine ratio for coronary artery abnormalities in Kawasaki disease.尿白蛋白与肌酐比值对川崎病冠状动脉异常的预测价值。
Front Pediatr. 2025 Jun 12;13:1583603. doi: 10.3389/fped.2025.1583603. eCollection 2025.
9
Heterogeneity in Kawasaki disease patients with coronary artery abnormalities investigated by data-driven cluster analysis.通过数据驱动的聚类分析研究川崎病合并冠状动脉异常患者的异质性。
Pediatr Res. 2025 Jun 20. doi: 10.1038/s41390-025-04205-8.
10
Impact of 10% vs. 5% immunoglobulin products on treatment outcomes in Kawasaki disease: a multicenter retrospective study.10%与5%免疫球蛋白产品对川崎病治疗结局的影响：一项多中心回顾性研究
Sci Rep. 2025 May 27;15(1):18502. doi: 10.1038/s41598-025-03395-9.